Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
PCVX Vaxcyte
- 81.060
- -6.230-7.14%
Close Jan 8 16:00 ET
- 82.500
- +1.440+1.78%
Post 20:01 ET
10.10BMarket Cap-17.62P/E (TTM)
86.425High80.830Low1.27MVolume86.160Open87.290Pre Close105.35MTurnover1.10%Turnover RatioLossP/E (Static)124.64MShares121.05552wk High2.96P/B9.32BFloat Cap58.10052wk Low--Dividend TTM114.99MShs Float121.055Historical High--Div YieldTTM6.41%Amplitude15.510Historical Low83.138Avg Price1Lot Size
About Vaxcyte Company
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
Company Profile
SymbolPCVX
Company NameVaxcyte
Listing DateJun 12, 2020
Issue Price16.00
Founded2013
CEOMr. Grant E. Pickering
MarketNASDAQ
Employees254
Fiscal Year Ends12-31
Address825 Industrial Road,Suite 300
CitySan Carlos
ProvinceCalifornia
CountryUnited States of America
Zip Code94070
Phone1-650-837-0111
Websitehttp://www.vaxcyte.com
Company Executives
- Name
- Position
- Salary
- Grant E. Pickering
- Director and Chief Executive Officer
- 12.14M
- Mikhail Eydelman
- Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
- --
- Jim Wassil
- Executive Vice President and Chief Operating Officer
- 5.40M
- Andrew L. Guggenhime
- Chief Financial Officer and President
- 5.42M
- Elvia Cowan
- Director, Senior Vice President, Finance and Principal Accounting Officer
- --
- Dr. Carlos V. Paya,M.D.,PhD
- Chairman of the Board
- 724.22K
- John P. Furey
- Independent Director
- --
- Teri Loxam
- Independent Director
- 704.22K
- Annie Seibold Drapeau
- Independent Director
- 704.22K
- Dr. Peter Hirth, PhD
- Independent Director
- 696.72K
- Dr. Heath Lukatch, PhD
- Independent Director
- 691.72K
- Jacks Lee
- Independent Director
- --
- Halley E. Gilbert
- Independent Director
- 704.22K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.